Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures

Completed · Phase 3

Conditions studied: Epilepsy

In brief

To provide continued treatment of Keppra XR (Levetiracetam XR) and to assess the long term safety of Keppra XR in subjects with partial onset seizures.

Key facts

Study ID
NCT00419393
Run by
UCB Pharma
People needed
190
Starts
2007-12-01
Expected to finish
2010-03-01
Last updated by the study team
2014-09-05

Who can join

Age: 12 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.